How many institutions held CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in Q2 2020?

187 institutional investors reported CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share for Q2 2020. Use the holders table for investor-level position and value details.

Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

Q: What does CUSIP 19249H103 represent in this 13F holders report?

CUSIP 19249H103 is the security identifier for CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 19249H103

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 153,624,096
Total 13F shares: 86,666,598
Share change: +12,210,490
Total reported value: $1,547,355,972
Put/Call ratio: 104%
Price per share: $17.86
Number of holders: 187
Value change: +$228,840,811
Number of buys: 113
Number of sells: 97

Quarterly Holders Quick Answers

What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 19249H103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Temasek Holdings (Private) Ltd	13F	Company	4.8%	7,381,116	$119,722,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	3.5%	5,452,560	$88,442,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	2.7%	4,124,245	$66,896,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	2.3%	3,502,994	$56,819,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	2.2%	3,438,334	$55,768,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	2.1%	3,226,324	$52,331,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	2%	3,126,609	$50,714,000	—	31 Mar 2020	13F
Kohlberg Kravis Roberts & Co. L.P.	13F	Company	2%	3,036,076	$49,245,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.5%	2,314,660	$37,544,000	—	31 Mar 2020	13F
Consonance Capital Management LP	13F	Company	1.3%	2,020,002	$32,764,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	1.3%	1,950,000	$31,629,000	—	31 Mar 2020	13F
Sofinnova Investments, Inc.	13F	Company	1.3%	1,933,221	$31,357,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1.2%	1,859,177	$30,155,853	—	31 Mar 2020	13F
Rubric Capital Management LP	13F	Company	1%	1,583,061	$25,677,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.98%	1,510,569	$24,502,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.94%	1,442,143	$23,392,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.81%	1,243,836	$20,175,000	—	31 Mar 2020	13F
Sio Capital Management, LLC	13F	Company	0.7%	1,077,839	$17,483,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.65%	994,939	$16,138,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.63%	968,982	$15,716,000	—	31 Mar 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	0.61%	941,781	$15,276,000	—	31 Mar 2020	13F
C WorldWide Group Holding A/S	13F	Company	0.59%	908,464	$14,735,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.59%	903,522	$14,654,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.51%	780,594	$12,661,000	—	31 Mar 2020	13F
BROWN ADVISORY INC	13F	Company	0.5%	761,152	$12,347,000	—	31 Mar 2020	13F
Hood River Capital Management LLC	13F	Company	0.48%	736,555	$11,947,000	—	31 Mar 2020	13F
Hound Partners, LLC	13F	Company	0.43%	665,444	$10,794,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.41%	625,603	$10,148,000	—	31 Mar 2020	13F
Impax Asset Management Group plc	13F	Company	0.34%	525,000	$8,516,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.34%	515,323	$8,358,000	—	31 Mar 2020	13F
NWQ INVESTMENT MANAGEMENT COMPANY, LLC	13F	Company	0.31%	478,180	$7,756,000	—	31 Mar 2020	13F
PFM Health Sciences, LP	13F	Company	0.31%	474,055	$7,689,000	—	31 Mar 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.31%	473,711	$7,555,000	—	31 Mar 2020	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.29%	438,891	$7,119,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	0.28%	430,000	$6,975,000	—	31 Mar 2020	13F
GLENVIEW CAPITAL MANAGEMENT, LLC	13F	Company	0.28%	426,738	$6,922,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.27%	408,968	$6,633,000	—	31 Mar 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.26%	394,928	$6,406,000	—	31 Mar 2020	13F
Avidity Partners Management LP	13F	Company	0.25%	382,000	$6,196,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.25%	381,289	$6,183,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.22%	337,795	$5,945,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.23%	359,100	$5,825,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.23%	353,446	$5,733,000	—	31 Mar 2020	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.23%	350,000	$5,677,000	—	31 Mar 2020	13F
FIL Ltd	13F	Company	0.21%	324,589	$5,265,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.21%	323,828	$5,252,000	—	31 Mar 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	0.19%	298,512	$4,842,000	—	31 Mar 2020	13F
FRIESS ASSOCIATES LLC	13F	Company	0.19%	290,580	$4,713,000	—	31 Mar 2020	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.18%	279,438	$4,683,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.18%	276,946	$4,492,000	—	31 Mar 2020	13F

Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q2 2020

As of 30 Jun 2020, Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by 187 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,666,598 shares. The largest 10 holders included BlackRock Inc., Temasek Holdings (Private) Ltd, STATE STREET CORP, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, Kohlberg Kravis Roberts & Co. L.P., Camber Capital Management LP, and Rock Springs Capital Management LP. This page lists 187 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

185

Q2 2020 holders

187

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.